Details

Autor(en) / Beteiligte

• Lacy, Antonio M., MD, PhD
• Tasende, Marta M., MD
• Delgado, Salvadora, MD, PhD
• Fernandez-Hevia, María, MD
• Jimenez, Marta, MD, PhD
• De Lacy, Borja, MD
• Castells, Antoni, MD, PhD
• Bravo, Raquel, MD
• Wexner, Steven D., MD, PhD, FACS
• Heald, Richard J., MD, PhD, FACS

Titel

Transanal Total Mesorectal Excision for Rectal Cancer: Outcomes after 140 Patients

Ist Teil von

• Journal of the American College of Surgeons, 2015-08, Vol.221 (2), p.415-423

Ort / Verlag

United States: Elsevier Inc

Erscheinungsjahr

2015

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• Background The anatomic difficulties that we have to deal with in open surgery for rectal cancer have not been overcome with the laparoscopic approach. In the search for a solution, a change of concept arose: approaching the rectum from below. The main objectives of this study were to show the potential advantages of the hybrid transabdominal-transanal total mesorectal excision (taTME). This approach may improve quality of the mesorectal specimens. Second, proctectomy can be technically easier and more safely performed “down to up,” which would result in shorter surgical times, lower conversion rates, and less morbidity. Study Design A prospective series of hybrid taTME was conducted from October 2011 to November 2014. Results During the study period, 140 procedures were performed. Mean operative time was 166 minutes. There were no conversions or intraoperative complications. Macroscopic quality assessment of the resected specimen was complete in 97.1% and nearly complete in 2.1%. Thirty-day morbidity was minor (Clavien-Dindo I + II) in 24.2% and major (Clavien-Dindo III + IV) in 10 %. No patient died within the first 30 days postsurgery (Clavien-Dindo V). The mean follow-up was 15 months, with a 2.3% local recurrence rate and a 7.6% rate of systemic recurrence. Conclusions Pathologic analysis showed a very good macroscopic quality of TME specimens, which is the most important prognostic factor in rectal cancer. Intraoperative outcomes regarding conversion, surgical times, and intraoperative complications are very satisfactory. Short-term morbidity and oncologic outcomes are as good as in other laparoscopic TME series.